Stratagene California
Stratagene California was an American biotechnological company based in La Jolla, California,[1] a maker of life science research and diagnostic products.[2] It was established in 1984 and incorporated in California.[3] It has been involved with the fields of cellular analysis, cloning, cytogenomics, DNA methylation and DNA Sizing and Quantification[1] and food testing. In 2007, Agilent Technologies acquired Stratagene for $250 million,[4] spinning off certain business assets and licensing certain molecular diagnostics technology to a new entity, Decisive Diagnostics.[5][2] As of October 2011, the Chief Executive of the new company is Joseph Sorge, original founder and CEO of Stratagene.[6]
References
[edit]- ^ a b Ahuja, M. R.; Boerjan, Wout; Neale, David B., eds. (1996). Somatic cell genetics and molecular genetics of trees. Springer. p. 198. ISBN 978-0-7923-4179-6. Retrieved 19 October 2011.
- ^ a b "Agilent Technologies Completes Stratagene Acquisition; Raises Q3 Revenue Outlook - Update". RTTNews. Retrieved 2020-07-14.
- ^ "Stratagene California". Manta.com. Retrieved 19 October 2011.
- ^ "Agilent Announce Definitive Agreement to Acquire Stratagene for $250 Million". Genomics Research from Technology Networks. Retrieved 2020-07-14.
- ^ "Agilent Technologies Adds Strength to Its Life Science Business with Acquisition of Stratagene". Agilent press release. Retrieved 28 December 2016.
- ^ "Joseph Sorge M.D." Bloomberg Businessweek. Archived from the original on September 29, 2013. Retrieved 19 October 2011.
Further reading
[edit]- Kraul, Chris (5 June 1987). "2 From Stratagene Win Entrepreneur of the Year Award". Los Angeles Times.
- Dalton, Rex (11 May 1990). "Firms' battle over 'silver bullet' technology opens in federal court". San Diego Union Tribune.
- Dalton, Rex (11 July 1991). "Biotech company plans partial move". San Diego Union Tribune.
- Somers, Terri (3 June 2004). "Stratagene acquires Hycor, goes public". San Diego Union Tribune.
- Gores, Paul (20 December 2005). "Judge triples damages in Third Wave case; $15.9 million awarded for patent infringement". Milwaukee Journal Sentinel.
- Somers, Terri (21 March 2006). "Innovation paying off: Profitable San Diego biotech tool company finds success in niche market". San Diego Union Tribune.
- Somers, Terri (7 April 2007). "La Jolla-based biotech bought for $245 million". San Diego Union Tribune.
External links
[edit]
 | This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |